Olezarsen and Beyond: Emerging Targeted Treatments for Familial Chylomicronemia Syndrome and Related Triglyceride Disorders

In familial chylomicronemia syndrome (FCS), a rare lipid disorder, triglycerides rise to extremely high levels because of the inability to utilize lipoprotein lipase (LPL) for fat metabolism. Traditional triglyceride-lowering medications are ineffective, leaving patients dependent on strict low-fat...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Meghashree N, Kushal C B, Shivaraj D R
Formato:	Artigo
Idioma:	Inglês
Publicado em:	The Korean Society of Lipid and Atherosclerosis 2026-01-01
coleção:	Journal of Lipid and Atherosclerosis
Assuntos:	chylomicronemia apolipoprotein c-3 olezarsen angiopoietin-like protein 3 gene therapy triglycerides
Acesso em linha:	https://www.e-jla.org/search.php?where=aview&id=10.12997/jla.2026.15.1.72&code=9992JLA&vmode=FULL
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!